PUMA BIOTECHNOLOGY, INC. (PBYI) Net income 2016–2025
PUMA BIOTECHNOLOGY, INC. (PBYI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$31.1MFY2025 · since FY2016: -$276.0M → $31.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $31.1M | +2.8% |
| FY2024 | $30.3M | +40.2% |
| FY2023 | $21.6M | +1079450.0% |
| FY2022 | $2,000 | +100.0% |
| FY2021 | -$29.1M | +51.5% |
| FY2020 | -$60.0M | +20.6% |
| FY2019 | -$75.6M | +33.4% |
| FY2018 | -$113.6M | +61.1% |
| FY2017 | -$292.0M | -5.8% |
| FY2016 | -$276.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PBYI financial trends
PBYI RevenuePBYI Net marginPBYI Gross profitPBYI Gross marginPBYI Operating incomePBYI Operating marginPBYI Operating cash flowPBYI Free cash flowPBYI Capital expendituresPBYI Return on equityPBYI Stock buybacksPBYI Dividends paidPBYI Total assetsPBYI Total liabilitiesPBYI Shareholders’ equityPBYI overview →